leisure time -WSS

leisure time

author：explore 2025-10-02 07:25:04 - browse：66447

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

focus

WSS

PBM reform efforts get punted in Congress

STAT readers on older presidents, polypills, Medicare, and more

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Medicare inequities exacerbate Puerto Rico’s health disparities

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Obesity drugs seen as possible treatment for liver disease MASH

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Antivenom research: Lessons from HIV applied in search for universal antidote

Dobbs anniversary: the lost opportunity of abortion as health care

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Cancer drug shortages should be causing more outrage

In medicine, common shorthands can shortchange care

Peter Hotez and the public health issue of online harassment

The UK government moves asylum

Hepatitis C has a cure — but many Americans still lack access to it

Alabama IVF ruling threatens families facing fatal genetic disease

explore

Obesity drugs seen as possible treatment for liver disease MASH

Illinois to ban advertising for guns allegedly marketed to kids and militants

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Antivenom research: Lessons from HIV applied in search for universal antidote

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

entertainment

focus

leisure time

knowledge